BioLife Solutions Inc (BLFS)

Pretax margin

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Earnings before tax but after interest (EBT)	US$ in thousands	-66,258	-144,827	-29,026	-1,281	-3,198
Revenue	US$ in thousands	142,625	160,996	118,837	48,087	27,366
Pretax margin		-46.46%	-89.96%	-24.43%	-2.66%	-11.69%

December 31, 2023 calculation

Pretax margin = EBT ÷ Revenue
= $-66,258K ÷ $142,625K
= -46.46%

The pretax margin of BioLife Solutions Inc has exhibited significant fluctuations over the past five years. In 2023, the pretax margin stood at -46.46%, a notable improvement compared to the previous year's figure of -89.96%. However, the company's performance in 2023 still reflects a negative margin, indicating that expenses continue to outpace revenue before accounting for taxes.

The substantial negative pretax margins in 2022 and 2021 indicate that the company faced challenges in generating profits or maintaining cost efficiency during those periods. The improvement in 2020, with the pretax margin decreasing to -2.66%, suggests a better financial performance compared to the preceding years.

Additionally, in 2019, the pretax margin was at -11.69%, showing a moderate improvement compared to 2022 and 2021 but still indicating a struggle to achieve profitability.

In conclusion, the pretax margin of BioLife Solutions Inc has fluctuated significantly over the past five years, with the company facing challenges in achieving profitability and cost efficiency. The recent improvement in the pretax margin in 2023 is a positive sign, although the company still has room for further enhancement in managing expenses and generating revenue.